The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis
Open accessAbstract
BACKGROUND: The tolerability of oral iron supplementation for the treatment of iron deficiency anemia is disputed. OBJECTIVE: Our aim was to quantify the odds of GI side-effects in adults related to current gold standard oral iron therapy, namely ferrous sulfate. METHODS: Systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating GI side-effects that included ferrous sulfate and a comparator that was either placebo or intravenous (i.v.) iron. Random effects meta-analysis modelling was undertaken and study heterogeneity was summarised using I2 statistics. RESULTS: Forty three trials comprising 6831 adult participants were included. Twenty trials (n = 3168) had a placebo arm and twenty three trials (n = 3663) had an active comparator arm of i.v. iron. Ferrous sulfate supplementation significantly increased risk of GI side-effects versus placebo with an odds ratio (OR) of 2.32 [95% CI 1.74-3.08, p<0.0001, I2 = 53.6%] and versus i.v. iron with an OR of 3.05 [95% CI 2.07-4.48, p<0.0001, I2 = 41.6%]. Subgroup analysis in IBD patients showed a similar effect versus i.v. iron (OR = 3.14, 95% CI 1.34-7.36, p = 0.008, I2 = 0%). Likewise, subgroup analysis of pooled data from 7 RCTs in pregnant women (n = 1028) showed a statistically significant increased risk of GI side-effects for ferrous sulfate although there was marked heterogeneity in the data (OR = 3.33, 95% CI 1.19-9.28, p = 0.02, I2 = 66.1%). Meta-regression did not provide significant evidence of an association between the study OR and the iron dose. CONCLUSIONS: Our meta-analysis confirms that ferrous sulfate is associated with a significant increase in gastrointestinal-specific side-effects but does not find a relationship with dose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These GI complaints cause up to 50% of oral iron receiving patients to not follow their treatment plan, meaning their IDA persists [9].”
From Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota (2021) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, it is well known that taking oral iron supplements associates with constipation [9].”
From Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota (2021) · cites this paper as [9]
In the citing paper
“Impaired gut health is a common reason for poor compliance with dietary iron supplementation regimens, even in high‐income countries. 183”
From The battle for iron in enteric infections (2020) · cites this paper as [183]
In the citing paper
“Supplements have the added advantage that they typically contain ferrous salts, which are more bioavailable than dietary iron [262], with a possible drawback of increased likelihood for gastrointestinal disturbances [263].”
From Nutritional Considerations for the Vegan Athlete (2023) · cites this paper as [263]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 2×
“Heterogeneity was assessed using the I(2) statistic and substantial heterogeneity exists when I(2)>50% [37].”
MethodMeta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 2×
“The random-effects model proposed by DerSimonian and Laird [35] was used for the meta-analysis.”
MethodThe Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Daily oral iron supplementation during pregnancy
Peña-Rosas, J. P., De-Regil, L. M., Dowswell, T., & Viteri, F. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004736.pub4 · Cited by 615 · cited 5×
“In trying to capture the true incidence of GI side-effects with oral iron therapy, discrepancies between studies and limitations of study design have made overall conclusions difficult to reach [11,14,15].”
BackgroundMethodResultInfluentialUK guidelines on the management of iron deficiency in pregnancy
Pavord, S., Myers, B., Robinson, S., Allard, S., Strong, J., Oppenheimer, C., & on behalf of the British Committee for Standards in Haematology (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.09012.x · Cited by 606 · cited 1×
“Groups mostly at risk include those with increased iron demands, for example children and pregnant women [3,4,5], and especially those with increased iron loses, for example pre-menopausal women [6] and patients with inflammatory bowel disease (IBD) [7,8].”
BackgroundZimmermann, M. B., Chassard, C., Rohner, F., N'Goran, E. K., Nindjin, C., Dostal, A., Utzinger, J., Ghattas, H., Lacroix, C., & Hurrell, R. F. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.004564 · Cited by 520 · cited 2×
“For very many years patient side-effects have been the main concern with oral iron therapy [16] but, recently, studies have consistently shown that soluble oral iron also negatively impacts the colonic microbiota, promoting the presence of potentially pathogenic bacteria at the expense of beneficial bacteria [17,18,19…”
BackgroundIron, anaemia, and inflammatory bowel diseases
Gasche, C., Lomer, M. C. E., Cavill, I., & Weiss, G. (2004) · Gut · doi:10.1136/gut.2003.035758 · Cited by 494 · cited 8×
“Subgroup analysis in IBD patients showed a similar effect versus IV iron (OR = 3.14, 95%CI 1.34-7.36, p = 0.008, I2 = 0%).”
BackgroundInfluentialDiagnosis and Management of Iron-Deficiency Anaemia
COOK, J. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.022 · Cited by 452 · cited 1×
“First-line treatment is oral therapy with ferrous iron (Fe(II)) salts [9].”
Background
Research works printed but not linked: 6
- L Hallberg, 1966, Side-effects of oral iron therapy. A double-blind study of different iron compounds in tablet form, Acta medica Scandinavica Supplementum, 180, 3, 10.1111/j.0954-6820.1966.tb19403.x · DOI
- R Langstaff, 1993, Treatment of iron-deficiency anaemia: A lower incidence of adverse effects with Ferrum Hausmann than ferrous sulphate, Br J Clin Res, 4, 191
- S Lindgren, 2009, Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study, Scand J Gastroenterol, 44, 838, 10.1080/00365520902839667 · DOI · Paper page
- C Gasche, 2011, Diagnosis and treatment of iron deficiency and anaemia in inflammatory bowel diseases. Consensus of the Austrian IBD Working Party, Z Gastroenterol, 49, 627
- L Saha, 2007, Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women, MedGenMed: Medscape general medicine, 9, 1
- Pacheco J Vazquez, 1980, A comparative study of i.v. iron dextran and an oral combination of ferrous sulfate, cyanocobalamin and folic acid in obstetrical patients, Investigacion Medica International, 7, 129
Cited by
Pasricha, S.-R., Tye-Din, J., Muckenthaler, M. U., & Swinkels, D. W. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32594-0 · Cited by 1,069
Camaschella, C. (2019) · Blood · doi:10.1182/blood-2018-05-815944 · Cited by 702
Stoffel, N. U., Cercamondi, C. I., Brittenham, G., Zeder, C., Geurts-Moespot, A. J., Swinkels, D. W., Moretti, D., & Zimmermann, M. B. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30182-5 · Cited by 435
Iron deficiency anaemia: pathophysiology, assessment, practical management
Kumar, A., Sharma, E., Marley, A., Samaan, M. A., & Brookes, M. J. (2022) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2021-000759 · Cited by 344
Lee, T., Clavel, T., Smirnov, K., Schmidt, A., Lagkouvardos, I., Walker, A., Lucio, M., Michalke, B., Schmitt-Kopplin, P., Fedorak, R., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-309940 · Cited by 324
Metadata
- Authors
- Tolkien, Z., Stecher, L., Mander, A. P., Pereira, D. I. A., & Powell, J. J.
- Affiliations
- MRC Elsie Widdowson Laboratory (GB)
- MRC Biostatistics Unit (GB)
- Corresponding author
- Pereira, Dora I. A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-02-20
- Volume
- 10
- Issue
- 2
- Pages
- e0117383
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4336293
- OpenAlex
- W2049123117
- Cited by
- 833
- References
- 86
- Citations by year
- 2026: 117 · 2025: 90 · 2024: 91 · 2023: 101 · 2022: 98 · 2021: 75 · 2020: 80 · 2019: 58 · 2018: 44 · 2017: 41 · 2016: 26 · 2015: 11
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- UNICEF
- Medical Research Council (U105960399, G0800860)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- ferrous sulfate, oral iron supplementation, gastrointestinal adverse effects, iron deficiency anemia, intravenous iron, tolerability, inflammatory bowel disease, pregnancy, iron dosage
- MeSH terms
- Clinical Trials as Topic, Ferrous Compounds, Gastrointestinal Diseases, Humans, Placebo Effect, Odds Ratio, Databases, Factual, Anemia, Iron-Deficiency, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1371/journal.pone.0117383
- The paper
- Tolkien, Z., Stecher, L., Mander, A. P., Pereira, D. I. A., & Powell, J. J. (2015). Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0117383
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.